Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The closing price of MBX Biosciences Inc (NASDAQ: MBX) was $16.69 for the day, down -0.36% from the previous closing price of $16.75. In other words, the price has decreased by -$0.36 from its previous closing price. On the day, 1.68 million shares were traded. MBX stock price reached its highest trading level at $17.6763 during the session, while it also had its lowest trading level at $16.47.
Ratios:
Our analysis of MBX’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 19.50 and its Current Ratio is at 19.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On August 05, 2025, Mizuho started tracking the stock assigning a Outperform rating and target price of $38.
On July 16, 2025, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $38.Oppenheimer initiated its Outperform rating on July 16, 2025, with a $38 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Sep 26 ’25 when Heron Patrick J bought 666,666 shares for $18.00 per share. The transaction valued at 11,999,988 led to the insider holds 5,219,440 shares of the business.
Pescovitz Ora H. bought 7,693 shares of MBX for $45,312 on Apr 08 ’25. The Director now owns 24,329 shares after completing the transaction at $5.89 per share. On Feb 18 ’25, another insider, GORDON CARL L, who serves as the Director of the company, bought 143,170 shares for $10.84 each. As a result, the insider paid 1,551,963 and bolstered with 3,255,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MBX now has a Market Capitalization of 746301632 and an Enterprise Value of 336425632.
Stock Price History:
The Beta on a monthly basis for MBX is 1.07, which has changed by -0.31033057 over the last 52 weeks, in comparison to a change of 0.17904854 over the same period for the S&P500. Over the past 52 weeks, MBX has reached a high of $27.50, while it has fallen to a 52-week low of $4.81. The 50-Day Moving Average of the stock is 20.64%, while the 200-Day Moving Average is calculated to be 39.51%.
Shares Statistics:
MBX traded an average of 1.08M shares per day over the past three months and 4669910 shares per day over the past ten days. A total of 33.59M shares are outstanding, with a floating share count of 20.67M. Insiders hold about 51.79% of the company’s shares, while institutions hold 42.94% stake in the company. Shares short for MBX as of 1757894400 were 4226517 with a Short Ratio of 3.91, compared to 1755216000 on 4065622. Therefore, it implies a Short% of Shares Outstanding of 4226517 and a Short% of Float of 25.15.
Earnings Estimates
The company has 4.0 analysts who recommend its stock at the moment. The consensus estimate for the next quarter is -$0.68, with high estimates of -$0.54 and low estimates of -$0.82.
Analysts are recommending an EPS of between -$2.32 and -$2.9 for the fiscal current year, implying an average EPS of -$2.64. EPS for the following year is -$2.51, with 5.0 analysts recommending between -$2.21 and -$2.75.
